06/05/2025
5:01 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:35 PM | ACADIA Pharmaceuticals (Subject)
Brege Laura (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
5:05 PM | ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2025
11:15 PM | ACADIA Pharmaceuticals (Filer)
| Form EFFECT | |
05/19/2025
7:50 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
7:52 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ACAD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ACADIA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/16/2025
4:06 PM | ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2025
4:10 PM | ACADIA Pharmaceuticals (Subject)
Schneyer Mark C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025
8:15 PM | ACADIA Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
6:59 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2025
7:00 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2025
3:49 PM | ACADIA Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2025
3:54 PM | ACADIA Pharmaceuticals (Filer)
| Form ARS | |
04/08/2025
6:38 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
6:40 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:52 PM | ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
7:03 PM | ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
7:06 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
7:10 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:49 PM | ACADIA Pharmaceuticals (Issuer)
Owen Adams Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
5:30 PM | ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
11:17 AM | ACADIA Pharmaceuticals (Subject)
GAROFALO ELIZABETH A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
4:26 PM | ACADIA Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
5:46 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
5:48 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:00 AM | ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
5:04 AM | ACADIA Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
12/11/2024
3:22 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
5:33 PM | ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:31 PM | ACADIA Pharmaceuticals (Issuer)
Garner Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/19/2024
7:40 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:41 PM | ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:43 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:48 AM | ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
10/15/2024
5:05 PM | ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
5:46 PM | ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
This Could Be the Most Profitable Season of Your Life (Ad) Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating.
This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending. Join The Crypto Code Workshop + get $10 in Bitcoin for attending |
09/25/2024
5:53 PM | ACADIA Pharmaceuticals (Issuer)
Adams Catherine Owen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:14 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/23/2024
3:34 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:40 PM | ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:43 PM | ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:46 PM | ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:37 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:39 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:23 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:25 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:27 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:29 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:31 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/20/2024
3:33 PM | ACADIA Pharmaceuticals (Filer)
| Form S-8 POS | |
08/13/2024
5:05 PM | ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:13 PM | ACADIA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
